- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Most Popular Stocks
Japanese Pharmaceuticals & Biotech Most Popular Stocks
Results
88
Most Popular Stocks on the market
88 companies
Precision System Science
Market Cap: JP¥5.4b
Develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products.
7707
JP¥195.00
7D
-6.3%
1Y
-28.6%
D. Western Therapeutics Institute
Market Cap: JP¥5.2b
A biotechnology company, focuses on discovery and development of various drugs.
4576
JP¥114.00
7D
-27.8%
1Y
52.0%
Delta-Fly Pharma
Market Cap: JP¥5.0b
Develops anticancer drugs.
4598
JP¥531.00
7D
-1.7%
1Y
-13.7%
Cyfuse Biomedical K.K
Market Cap: JP¥5.0b
Engages in the development, manufacture, and sale of regenerative medicine products in Japan.
4892
JP¥619.00
7D
4.7%
1Y
5.6%
Perseus Proteomics
Market Cap: JP¥4.6b
A drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan.
4882
JP¥310.00
7D
-6.3%
1Y
-52.5%
Veritas In Silico
Market Cap: JP¥4.5b
Engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA.
130A
JP¥687.00
7D
-4.1%
1Y
-34.3%
Immuno-Biological Laboratories
Market Cap: JP¥4.4b
Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.
4570
JP¥467.00
7D
-1.7%
1Y
6.9%
Human Metabolome Technologies
Market Cap: JP¥4.3b
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.
6090
JP¥731.00
7D
-1.1%
1Y
19.1%
FunPep
Market Cap: JP¥4.2b
Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.
4881
JP¥105.00
7D
-0.9%
1Y
-25.5%
Ribomic
Market Cap: JP¥4.2b
Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.
4591
JP¥94.00
7D
0%
1Y
17.5%
Carna Biosciences
Market Cap: JP¥3.9b
A clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.
4572
JP¥208.00
7D
-7.6%
1Y
-43.6%
Kubota Pharmaceutical Holdings
Market Cap: JP¥3.7b
Develops portfolio of drugs and devices worldwide.
4596
JP¥63.00
7D
-3.1%
1Y
1.6%
Transgenic Group
Market Cap: JP¥3.5b
Develops, distributes, and licenses genetically modified animals and antibodies in Japan.
2342
JP¥208.00
7D
-5.5%
1Y
-13.3%
Kringle Pharma
Market Cap: JP¥3.1b
Engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines.
4884
JP¥439.00
7D
-7.8%
1Y
-48.6%
atect
Market Cap: JP¥1.9b
Engages in the sanitation inspection equipment, powder injection molding (PIM), and semiconductor material businesses.
4241
JP¥447.00
7D
-0.2%
1Y
-13.2%
PhoenixBio
Market Cap: JP¥1.6b
Provides contract study services for drug discovery and development primarily in Japan.
6190
JP¥396.00
7D
-5.0%
1Y
-10.2%